Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?

INTRODUCTION: Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an important marker of cardiovascular risk and a new target for therapeutic interventions. We aimed to study the influence of metformin on the level of circulating PCSK9 in patients with stable coronary artery disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arch Med Sci Atheroscler Dis
Main Authors: Shek, Aleksandr B., Alieva, Rano B., Kurbanov, Ravshanbek D., Hoshimov, Shavkat U., Nizamov, Ulugbek I., Ziyaeva, Adolat V.
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704763/
https://ncbi.nlm.nih.gov/pubmed/31448346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/amsad.2019.86752
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados